The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cutis (New York, N.Y.)

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 12096825
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Contribution of the combined oral contraceptive ethinylestradiol 20 µg/dienogest 2 mg, in the treatment of mild to moderate acne vulgaris and its perceived psychological effects in young university women

  2025cites this paper
• Polycystic ovary syndrome and estroprogestins.

  2025cites this paper
• Predictable benefits of folate-containing combined oral contraceptives after abortion in women: review

  2022cites this paper
• Androgens and Acne

  2021cites this paper
• Treatment challenges in adult female acne and future directions

  2021cites this paper
• A prospective randomized trial comparing two different oral contraceptive containing dienogest or drospirenone for the treatment of hirsutism in policystic ovarian syndrome

  2020cites this paper
• A comparison of the effects of oral contraceptives on the clinical and biochemical manifestations of polycystic ovary syndrome: a crossover randomized controlled trial.

  2020cites this paper
• ANTIBIOTIC ACTIVITY AND ANTIBIOTIC RESISTANCE OF PURE CULTUR OF PROPIONIBACTERIUM FREUDENREICHII SH-85 AND ACIDOPHILUS BACILLUS FOR FURTHER USE OF CULTURES IN THE PRODUCTION OF BACTERIAL CONCENTRATE

  2020cites this paper
• Hydrogel-Based Active Substance Release Systems for Cosmetology and Dermatology Application: A Review

  2020cites this paper
• Influence of Contraception Class on Incidence and Severity of Acne Vulgaris.

  2020cites this paper
• A current perspective into young female sex hormone replacement: a review

  2020cites this paper
• Managing Women’s Hyperandrogenism

  2019cites this paper
• Polikistik Over Sendromunda Hirsutizm Tedavisi İçin Dienogest veya Drospirenon İçeren İki Farklı Oral Kontraseptifin Karşılaştırıldığı Prospektif Randomize Bir Çalışma

  2019cites this paper
• Etiology and Treatment Progress of Adolescent Polycystic Ovary Syndrome

  2019cites this paper
• Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.

  2019cites this paper
• Androgens in women: Hormone-modulating therapies for skin disease.

  2019cites this paper
• Effect of chlormadinone acetate versus drospirenone-containing oral contraceptives on the endocrinal features of women with polycystic ovary syndrome: Systematic review and meta-analysis of randomized clinical trials.

  2019cites this paper
• Adult-onset acne: prevalence, impact, and management challenges

  2018cites this paper
• A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

  2018cites this paper
• A Review of hormone-based therapies to treat adult acne vulgaris in women

  2017cites this paper
• Spironolactone for the treatment of acne in women, a retrospective study of 110 patients

  2017cites this paper
• Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review

  2017cites this paper
• Chemical pharmacotherapy options for managing adult acne

  2017cites this paper
• Oily Skin: A review of Treatment Options.

  2017cites this paper
• The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review

  2017cites this paper
• Polycystic ovary syndrome in adolescents.

  2017cites this paper
• THE MODERN APPROACH TO THE COMPLEX THERAPY OF DEMODICOSIS

  2016influential citation
• Ethinyl Estradiol-Drospirenon Versus Vitex Agnus-Castus Extract in Efficacy of the Treatment of Premenstrual Syndrome

  2016cites this paper
• Use of Oral Contraceptives for Management of Acne Vulgaris: Practical Considerations in Real World Practice.

  2016cites this paper
• COMPASS Therapeutic Notes on the Primary Care Management of Acne in Primary Care

  2016cites this paper
• COMPASS Therapeutic Notes on the Primary Care Management of Acne in Primary Care

  2016cites this paper
• Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments

  2016cites this paper
• Management of acne vulgaris with hormonal therapies in adult female patients

  2015cites this paper
• [Evidence-based therapy of polycystic ovarian syndrome].

  2015cites this paper
• Interventions for hirsutism (excluding laser and photoepilation therapy alone).

  2015cites this paper
• Nanomedical strategies for targeting skin microbiomes.

  2015cites this paper
• Is hormonal treatment still an option in acne today?

  2015cites this paper
• Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A randomized controlled trial

  2015cites this paper
• The Polycystic Ovary Syndrome and Acne

  2014cites this paper
• Acne in hirsute women

  2014cites this paper
• Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.

  2014cites this paper
• Therapy in endocrine disease: treatment of hirsutism in the polycystic ovary syndrome.

  2014cites this paper
• The management of patients with polycystic ovary syndrome

  2014cites this paper
• Treatment of hirsutism in the polycystic ovary syndrome

  2014cites this paper
• Severe teenage acne and risk of endometriosis.

  2014cites this paper
• Epidemiology and Management of Acne in Adult Women

  2014cites this paper
• Polycystic ovary syndrome: a review for dermatologists: Part I. Diagnosis and manifestations.

  2014cites this paper
• Nanotechnological advances in cutaneous medicine

  2013cites this paper
• Treatment of acne in women ovarian hyperandrogenism and insulin resistance

  2013cites this paper
• Effects of an oral contraceptive containing estradiol valerate and dienogest on circulating androgen levels and acne in young patients with PCOS: an observational preliminary study

  2013cites this paper
• Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study

  2013cites this paper
• Lasers and Light Sources for Medical Dermatologic Conditions

  2013cites this paper
• Tratamiento hormonal del acné

  2013cites this paper
• Combined oral contraceptive pills for treatment of acne.

  2012cites this paper
• Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation

  2012cites this paper
• Acne in the adult female patient: a practical approach

  2012cites this paper
• A historical cycle control comparison of two drospirenone-containing combined oral contraceptives: ethinylestradiol 30 μg/drospirenone 3 mg administered in a 21/7 regimen versus ethinylestradiol 20 μg/drospirenone 3 mg administered in a 24/4 regimen.

  2012cites this paper
• Contraceptives with novel benefits

  2012cites this paper
• Comprehensive Evaluation of Safyral® 2012

  2012cites this paper
• Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women.

  2012cites this paper
• Combined oral contraceptive pills for treatment of acne.

  2012cites this paper
• Guidance on the diagnosis and clinical management of acne

  2012cites this paper
• Original research article Suppression of ovarian activity with a low-dose 21/7-day regimen oral contraceptive containing ethinylestradiol 20 mcg/drospirenone 3 mg in Japanese and Caucasian women ☆

  2012cites this paper
• Interventions for actinic keratoses.

  2012cites this paper
• Oral Contraceptive Pills: Combinations, Dosages and the Rationale behind 50 Years or Oral Hormonal Contraceptive Development

  2011cites this paper
• Commentary on ‘Combined oral contraceptive pills for treatment of acne’

  2011cites this paper
• A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism.

  2011cites this paper
• Use of oral contraceptives in the management of acne

  2011cites this paper
• Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.

  2011cites this paper
• Management of acne

  2011cites this paper
• Intense pulse light (IPL)

  2011cites this paper
• Cochrane Review: Combined oral contraceptive pills for treatment of acne

  2011cites this paper
• Drospirenone/Ethinylestradiol: A Review on Efficacy and Noncontraceptive Benefits

  2011cites this paper
• Interventional studies for polycystic ovarian syndrome in children and adolescents.

  2010cites this paper
• Diagnóstico y manejo del síndrome de ovario poliquístico: una perspectiva dermatológica

  2010cites this paper
• Mechanism of action of liver growth induced by peroxisome proliferators

  2010cites this paper
• S2k – Guideline on the Therapy of Acne

  2010cites this paper
• Current procedures for managing polycystic ovary syndrome

  2010cites this paper
• Effects of Oral Contraceptives Containing Ethinylestradiol with Either Drospirenone or Levonorgestrel on Various Parameters Associated with Well-Being in Healthy Women

  2010cites this paper
• Disorders of the Sebaceous Glands

  2010cites this paper
• Hormonelle Antiandrogene in der Aknetherapie

  2010cites this paper
• S2k‐Leitlinie zur Therapie der Akne

  2010cites this paper
• Can sebum reduction predict acne outcome?

  2010cites this paper
• [Acne and hormonal contraceptives].

  2010cites this paper
• Treating acne vulgaris: systemic, local and combination therapy

  2010cites this paper
• Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome.

  2010cites this paper
• The Hong Kong Medical Diary

  2010cites this paper
• Acné et contraception hormonale

  2010cites this paper
• Combined oral contraceptive pills for treatment of acne.

  2009cites this paper
• The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

  2009cites this paper
• User Satisfaction with the Combined Oral Contraceptive Drospirenone 3m g/Ethinylestradiol 20 mg (Yasminelle

  2009cites this paper
• Acne in gynecological practice

  2009cites this paper
• Welcome developments in contraception

  2009cites this paper
• Overview of new therapeutic developments for acne

  2009cites this paper
• Palabras Clave: Drospirenona; síndrome premenstrual; trastorno disfórico premenstrual; menopausia; tratamiento hormonal de la menopausia; hipertensión. Drospirenona, de la etapa reproductiva a la postmenopausia

  2009cites this paper
• Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome

  2009cites this paper
• Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne

  2009cites this paper
• Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.

  2009cites this paper
• User Satisfaction with the Combined Oral Contraceptive Drospirenone 3 mg/Ethinylestradiol 20 μg (Yasminelle®) in Clinical Practice

  2009influential citation
• Psychosexual well-being in women using oral contraceptives containing drospirenone.

  2009cites this paper